Can I stop taking Everolimus (Afinitor) at will after taking it?
Everolimus (Everolimus) is a targeted drug that is widely used in the treatment of organ transplant rejection, renal cell carcinoma, breast cancer and certain neuroendocrine tumors. It plays a therapeutic role by inhibiting the mTOR signaling pathway to prevent cell proliferation and tumor growth. Since the pharmacological effect of everolimus relies on the maintenance of continuous blood concentration, arbitrary discontinuation of the drug during medication may affect the efficacy or even lead to recurrence of the condition.
Clinically, if patients suddenly stop taking medication without the guidance of a doctor, they may be at risk of worsening or relapse. For example, organ transplant patients may be at risk of rejection, while cancer patients may experience rapid tumor progression. Therefore, everolimus usually needs to be taken long-term and regularly in accordance with medical advice, and blood concentration and liver and kidney function must be reviewed regularly to ensure safe and effective treatment.
During the treatment process, if serious side effects or uncomfortable symptoms occur, the patient should communicate with the attending doctor in time instead of stopping the medication on his own. Doctors may adjust the dosage, extend the medication interval, or take symptomatic treatment measures based on the specific situation to minimize side effects while maintaining drug efficacy. Common side effects include oral ulcers, increased risk of infection, hyperglycemia, hyperlipidemia, etc. A comprehensive assessment is required to decide whether to adjust the medication plan.
In short, everolimus should not be stopped at will, and patients should strictly follow the doctor's instructions. Discontinuation or dosage adjustment must be done under the guidance of a professional physician to avoid a decrease in efficacy and worsening of the condition. At the same time, patients should maintain regular check-ups, pay attention to their own body reactions, and seek medical treatment promptly when abnormalities occur. Scientific and standardized medication management is the key to ensuring the efficacy and safety of everolimus.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)